MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Genetic Testing Of Degenerative Eye Disease

Back to ophthalmology news Blogs list Cancer blog  


Subscribe To Ophthalmology News RSS Feed  RSS content feed What is RSS feed?

Genetic Testing Of Degenerative Eye Disease

Genetic Testing Of Degenerative Eye Disease
ANN ARBOR, Mich. Genetic testing for eye disease is providing vital information about complex retinal diseases, particularly when used to confirm a clinicians diagnosis.

In a newly published review of such tests that were conducted over a five-year period at the University of Michigan Kellogg Eye Center, researchers were able to confirm a clinicians diagnosis in half of the cases. The testing took place in the laboratory of Radha Ayyagari, Ph.D., director of Kelloggs Ophthalmic Molecular Diagnostic Laboratory.

In the recent issue of Archives of Ophthalmology, Ayyagari and her colleagues report on 350 genetic tests conducted since 1999, when the U-M Ophthalmic Molecular Diagnostic Laboratory became one of the first laboratories in the nation to receive government approval for ophthalmic testing under the Clinical Laboratory Improvement Amendment (CLIA). For each test described in the current study, researchers analyzed one or more of eight genes known to cause diseases of the retina.

Of the 350 tests, 266 were performed to confirm a clinicians diagnosis, by far the most common use of genetic testing for eye disease. Another 75 tests sought to determine whether an individual was a carrier of a disease, and nine tests were used to predict the likelihood that an individual with a family history of a given eye disease would go on to develop it.

Ayyagaris team was able to determine the molecular basis of the disease in half of 266 tests conducted to confirm a diagnosis. These results are significant because a number of retinal diseases present similar symptoms, and it is sometimes difficult for even the most skilled specialist to distinguish one from the other. By comparing a patients DNA to known disease-causing genes, researchers deliver information needed to confirm or rule out a diagnosis. To date, researchers have identified over 130 genes linked to retinal disease, such as retinitis pigmentosa and macular degeneration.

The authors observe that genetic testing for eye disease is a relatively new and evolving practice. Says Ayyagari, Molecular diagnostics does not replace the necessary expertise of the ophthalmologist; rather, it adds a new tool to the ophthalmologists diagnostic arsenal.

The report describes one case in which parents with no family history of retinal degeneration requested genetic testing in hopes of revealing the specific nature of their sons eye disease. They also wanted to know whether the younger son, who was experiencing more subtle symptoms, had the same disease or a milder vision problem due to a different disease. Testing revealed that both boys had two gene mutations associated with Stargardts macular degeneration, a blinding disease that begins in childhood.

Genetic counseling is a crucial part of the genetic testing process, especially when the patient may face the possibility of blindness, says Ayyagari. The family needs to prepare for all possible test results, understand the implications of test results for the patient and other family members, and be aware of the limitations of genetic testing. If physicians do not have the time or skills to provide this background, Ayyagari urges them to refer their patients to genetic counselors.

The study also reported that a diagnosis could not be confirmed in 133 cases, or half the tests conducted to confirm a diagnosis. It is very difficult for patients to understand that the test may not be definitive, says Ayyagari. Genetic testing may not always yield the firm facts we receive in other kinds of testing, such as blood tests for cholesterol levels.

A related point of confusion is that an inconclusive result does not necessarily rule out a diagnosis for a given disease. Limitations still exist in technologies for genetic testing, explains Ayyagari. In addition, very slight genetic variations thought to benon-malignant may have either a cumulative effect or may alter the way another gene functions. Finally, while there has been great progress, researchers have yet to identify all the genes that contribute to disease of the retina.

Tomorrow we may discover a new gene that explains a number of of the previously inconclusive test reports, says Ayyagari.

In a related paper in the same issue of Archives of Ophthalmology, Stephen Daiger, Ph.D., University of Texas Health Science Center, writes on the promise of genetic testing for eye disease. He says, Across all of the categories of inherited retinopathy, careful screening of known disease genes leads to detection of pathogenic mutations in 25% to 90% of patients, an extraordinary accomplishment.

It is to the patients advantage to have a molecular diagnosis on file, observes Ayyagari. When therapys begin to emerge for these complex genetic diseases, she says, the individuals genotype may determine whether a new therapy will be the one that works for that patient.


Posted by: Mike    Source




Did you know?
ANN ARBOR, Mich. Genetic testing for eye disease is providing vital information about complex retinal diseases, particularly when used to confirm a clinicians diagnosis. In a newly published review of such tests that were conducted over a five-year period at the University of Michigan Kellogg Eye Center, researchers were able to confirm a clinicians diagnosis in half of the cases. The testing took place in the laboratory of Radha Ayyagari, Ph.D., director of Kelloggs Ophthalmic Molecular Diagnostic Laboratory.

Medicineworld.org: Genetic Testing Of Degenerative Eye Disease

Cancer terms| History of cancer| Imaging techniques| Cancer Main| Bladder cancer news| Cervix cancer news| Colon cancer news| Esophageal cancer news| Gastric cancer news| Health news| Lung cancer news| Breast cancer news| Ovarian cancer news| Cancer news| Pancreatic cancer news| Prostate cancer news| Endometrial cancer news| General info| What is cancer?| Cancer causes| Is cancer hereditary?| Types of cancer| Cancer statistics| Breast cancer main| Breast cancer symptoms| Colon cancer main| Anal cancer| Bladder cancer main| Lung cancer general| Lung cancer main| Non small cell| Small cell| Ovarian cancer main| Treatment of ovarian cancer| Prostate cancer main| Updates in oncology| Acute myeloid leukemia|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.